pA2 online
© Copyright 2004 The British Pharmacological Society

006P University of Newcastle
Winter Meeting December 2004

modulation of sensory neurone excitability and K+ conductances by the endocannabinoid, anandamide

Rhian M. Evans, Kerrie N. Wease, Charlotte J. Macdonald, Ruth A. Ross & Roderick H. Scott, School of Medical Sciences, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen AB25 2ZD, UK .

Print abstract

Search PubMed for:


Evans RM
Wease KN
Macdonald CJ
Ross RA
Scott RH

Plant, synthetic and endogenous cannabinoids can modulate the excitability of sensory neurones, and this may be of benefit in the treatment of pain disorders ( Ross et al., 2004) . The endocannabinoid, anandamide (arachidonoyl ethanolamide; AEA) has dual effects, enhancing or inhibiting depolarisation-activated Ca2+ influx in cultured dorsal root ganglion (DRG) neurones. However, only the inhibitory responses to AEA were sensitive to pertussis toxin pre-treatment suggesting distinct mechanisms of action ( Evans et al., 2004) .

In this study we have used cultured DRG neurones from 2-day old Sprague-Dawley rats, the whole cell patch clamp recording method and fura-2 Ca2+ imaging to investigate the possible modulation of K+ conductances by AEA. AEA (1 µM; with 0.01 % DMSO) reduced the burst firing behaviour of a sub-population (~20 %) of DRG neurones and caused a slowing of the repolarising phase of action potentials. AEA (1 µM) inhibited voltage-activated K+ currents evoked from a holding potential of –70 mV by 100 ms voltage step commands to +30 mV by 24 ± 6 % (n=7; P<0.03) and partial recovery was seen 10-30 minutes after removing the drug perfusion pipette from the bath. Pre-treatment for 16-24 hrs with pertussis toxin (500 ng/ml) did not attenuate AEA-evoked inhibition of K+ currents, the inhibition being 30 ± 5 %; n=11. Co-application of AEA with the cannabinoid receptor antagonist, SR141716A (100 nM) also failed to attenuate the inhibition of K+ currents by AEA, the inhibition being 38 ± 8 %; n=5. Application of SR141716A alone had no significant effect on K+ currents (n=7). The action of AEA was not mimicked by non-hydrolysable methanandamide, which failed to modulate the K+ current (n=5). This indicated that AEA metabolites may play a critical role in the modulation of K+ conductances in DRG neurones. Additional evidence supporting this hypothesis was that pre-treating neurones with the fatty acid amide hydrolase (FAAH) inhibitor phenylmethylsulfonyl fluoride (PMSF; 10 µM) attenuated the effects of AEA. Under these conditions the mean K+ current amplitude was not significantly different from control. Consistently, a primary metabolite of AEA, arachidonic acid (1 µM) also inhibited K+ currents by 26 ± 5% (n=11).

These data indicate that, in addition to the established CB1 receptor-mediated modulation of K+ conductances, AEA also displays properties that are consistent with the production of active metabolites.

Evans, R., Scott, R. & Ross, R. (2004) Multiple actions of anandamide on neonatal rat cultured sensory neurones. Br. J. Pharmacol.,141, 1223-1233.
Ross, R., Evans, R. & Scott, R. (2004) Cannabinoids and sensory neurones. Current Neuropharmacology. 2 , 59-73.

This work was funded by The Wellcome Trust and the University of Aberdeen.